ロード中...
Development of Alzheimer’s Disease Biomarkers: From CSF- to Blood-Based Biomarkers
In the 115 years since the discovery of Alzheimer’s disease (AD), our knowledge, diagnosis, and therapeutics have significantly improved. Biomarkers are the primary tools for clinical research, diagnostics, and therapeutic monitoring in clinical trials. They provide much insightful information, and...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI AG
2022-04-01
|
| シリーズ: | Biomedicines |
| 主題: | |
| オンライン･アクセス: | https://www.mdpi.com/2227-9059/10/4/850 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|